2012
DOI: 10.1021/tx300292h
|View full text |Cite
|
Sign up to set email alerts
|

Full Structure Assignments of Pyrrolizidine Alkaloid DNA Adducts and Mechanism of Tumor Initiation

Abstract: Pyrrolizidine alkaloid-containing plants are widespread in the world and are probably the most common poisonous plants affecting livestock, wildlife, and humans. Pyrrolizidine alkaloids are among the first chemical carcinogens identified in plants. Previously, we determined that metabolism of pyrrolizidine alkaloids in vivo and in vitro generated a common set of DNA adducts that are responsible for tumor induction. Using LC-ESI/MS/MS analysis, we previously determined that four DNA adducts (DHP-dG-3, DHP-dG-4,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
81
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(88 citation statements)
references
References 34 publications
6
81
0
1
Order By: Relevance
“…According to the study of Xia et al (2013), DNA adduct formation is a common biological biomarker of PAinduced tumorigenicity in rats. Previous studies reported that the metabolism of riddelliine by human liver microsomes resulted in a similar metabolic pattern and DNA adduct profile to those formed in the rat liver, suggesting that the mode of action of PAs studied in experimental rodents is highly relevant to humans (Xia et al 2003;Zhao et al 2012). The current PBK model could also translate in vitro concentration-response curves for DNA adduct formation in human liver cells to in vivo dose-response curves for DNA adduct formation in the liver of human.…”
Section: Discussionmentioning
confidence: 80%
“…According to the study of Xia et al (2013), DNA adduct formation is a common biological biomarker of PAinduced tumorigenicity in rats. Previous studies reported that the metabolism of riddelliine by human liver microsomes resulted in a similar metabolic pattern and DNA adduct profile to those formed in the rat liver, suggesting that the mode of action of PAs studied in experimental rodents is highly relevant to humans (Xia et al 2003;Zhao et al 2012). The current PBK model could also translate in vitro concentration-response curves for DNA adduct formation in human liver cells to in vivo dose-response curves for DNA adduct formation in the liver of human.…”
Section: Discussionmentioning
confidence: 80%
“…These studies contributed to riddelliine’s classification as a potential human carcinogen [43]. More recently Zhao et al have shown that dehydroriddelliine preferentially binds at the C9 position of DNA forming epimers of 7-hydroxy-9-(deoxyadenosin- N -6-yl) dehydrosupinidine and 7-hydroxy-9-(deoxyguanosin- N -2-yl) dehydrosupinidine and that these adducts are responsible for riddelliine carcinogenesis at a molecular level [44]. It may be riddelliine is unique and produces many more adducts than similar DHPAs.…”
Section: Discussionmentioning
confidence: 99%
“…1,30−35 The DNA adducts are a pair of epimers of 7-hydroxy-9-(deoxyguanosin-N 2 -yl) dehydrosupinidine (DHP− dG-3 and DHP−dG-4) and a pair of epimers of 7-hydroxy-9-(deoxyadenosin-N 6 -yl)dehydrosupinidine (DHP−dA-3 and DHP−dA-4). 35 Further studies demonstrated that DHP−dG-3, DHP−dG-4, DHP−dA-3, and DHP−dA-4 were also formed in the liver of rats treated with seven hepatocarcinogenic pyrrolizidine alkaloids and riddelliine N-oxide. 36 These results indicate that this set of DNA adducts is a common biological biomarker of pyrrolizidine alkaloid-induced liver tumor formation.…”
Section: ■ Introductionmentioning
confidence: 99%